Inspired by the initial use of IL10−/− mice as a clinical model for campylobacteriosis developed by Mansfield et al. [56] and Lippert et al. [117], our group has generated a similar experimental model for severe campylobacteriosis. Here, IL10 is linked to campylobacteriosis.